Literature DB >> 7856561

Virus-associated hemophagocytic syndrome characterized by clonal Epstein-Barr virus genome.

M V Dolezal1, O W Kamel, M van de Rijn, M L Cleary, R K Sibley, R A Warnke.   

Abstract

Virus-associated hemophagocytic syndromes are a heterogeneous group of disorders in which viral infection is associated with a proliferation of hemophagocytic histiocytes throughout the reticuloendothelial system. The authors report the case of a 24-year-old Vietnamese male who developed a hemophagocytic syndrome associated with Epstein-Barr virus (EBV) and who died following a rapidly progressive course. A proliferation of reactive-appearing lymphoid cells was associated with an extensive proliferation of erythrophagocytic histiocytes. Immunophenotypically, the lymphoid infiltrate consisted of CD56+ natural killer cells, predominantly CD8+ T-cells and rare B-cells (CD20+). Double-label immunohistochemical studies showed CD3+ T-cells and CD56+ natural killer cells to be distinct cell populations. Combined immunohistochemical-in situ hybridization studies localized EBV to CD43+, CD3-, CD68-, lymphoid-appearing cells, indicating the presence of EBV within natural killer cells. Southern hybridization analysis of EBV genomic termini revealed clonal EBV genome. However, there was no detectable immunoglobulin or T-cell receptor gene rearrangements. The findings indicate that this case of hemophagocytic syndrome represents a clonal proliferation of natural killer cells containing EBV and highlights the importance of the analysis of EBV genomic termini for determination of clonality in EBV-associated proliferations. It is possible that other cases of fulminant EBV-associated hemophagocytic syndromes represent clonal natural killer cell proliferations.

Entities:  

Mesh:

Year:  1995        PMID: 7856561     DOI: 10.1093/ajcp/103.2.189

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits.

Authors:  K Hayashi; N Ohara; N Teramoto; S Onoda; H L Chen; T Oka; E Kondo; T Yoshino; K Takahashi; J Yates; T Akagi
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.

Authors:  Megan C Smith; Daniel N Cohen; Bruce Greig; Ashwini Yenamandra; Cindy Vnencak-Jones; Mary Ann Thompson; Annette S Kim
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS.

Authors:  Kazuhiko Hayashi; Zaishun Jin; Sachiyo Onoda; Hiromasa Joko; Norihiro Teramoto; Nobuya Ohara; Wakako Oda; Takehiro Tanaka; Yi-Xuan Liu; Tirtha Raj Koirala; Takashi Oka; Eisaku Kondo; Tadashi Yoshino; Kiyoshi Takahashi; Tadaatsu Akagi
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

4.  The serum cytokine profiles of lymphoma-associated hemophagocytic syndrome: a comparative analysis of B-cell and T-cell/natural killer cell lymphomas.

Authors:  Tatsuharu Ohno; Yasunori Ueda; Ken-ichi Nagai; Takayuki Takahashi; Yoshiteru Konaka; Teruyuki Takamatsu; Takayo Suzuki; Masataka Sasada; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

5.  Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy.

Authors:  Ken H Young; Dahua Zhang; Jeffery T Malik; Eliot C Williams
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

6.  Fulminant Epstein-Barr virus-associated T-cell lymphoproliferative disorder in an immunocompetent middle-aged man presenting with chronic diarrhea and gastrointestinal bleeding.

Authors:  Jamshid Abdul-Ghafar; Jae Woo Kim; Kwang Hwa Park; Mee-Yon Cho
Journal:  J Korean Med Sci       Date:  2011-07-28       Impact factor: 2.153

7.  Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature.

Authors:  Valentina Tabanelli; Claudio Agostinelli; Elena Sabattini; Anna Gazzola; Francesco Bacci; Saveria Capria; Claudia Mannu; Simona Righi; Maria Teresa Sista; Giovanna Meloni; Stefano A Pileri; Pier Paolo Piccaluga
Journal:  J Med Case Rep       Date:  2011-06-07

8.  Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis.

Authors:  Ho-Jin Shin; Joo Seop Chung; Je-Jung Lee; Sang Kyun Sohn; Young Jin Choi; Yeo-Kyeoung Kim; Deok-Hwan Yang; Hyeoung-Joon Kim; Jong Gwang Kim; Young Don Joo; Won Sik Lee; Chang-Hak Sohn; Eun Yup Lee; Goon Jae Cho
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.